Safety of blood-pressure drug reviewed

Health Canada is reviewing the safety of the blood-pressure drug Rasilez after its manufacturer halted a large study that showed the medication could have adverse effects when combined with some other prescription drugs.

Health Canada is reviewing the safety of the blood-pressure drug Rasilez after its manufacturer halted a large study that showed the medication could have adverse effects when combined with some other prescription drugs.

The ALTITUDE study was trying to determine whether Rasilez (aliskiren) could reduce the risk of cardiovascular and kidney problems in patients with diabetes and renal impairment when taken with other blood pressure-lowering drugs.

Novartis terminated the multinational clinical trial after interim data suggested Rasilez was unlikely to benefit those patients and could potentially cause harm.

Specifically, when used in combination with drugs known as ACE-inhibitors or angiotensin receptor blockers (ARBs), Rasilez was associated with an increased risk of non-fatal stroke, kidney complications, high levels of potassium in the blood and low blood pressure.

Rasilez is currently authorized in Canada for use either alone or in combination with other drugs, including ACE-inhibitors and ARBs to control high blood pressure.

Health Canada said it is evaluating available safety data, including information from Novartis and international regulatory bodies, to determine if prescribing changes are needed.

As a precautionary measure, Novartis has said it is no longer promoting Rasilez use in combination with an ACE-inhibitor or ARB drugs.

Consumers taking Rasilez either alone or in combination with other blood pressure-reducing drugs who have questions or concerns should talk to their health professional.

They should not stop treatment without consulting their health-care professional.

If untreated, high blood pressure can cause serious health effects over time.

The ALTITUDE study involved 8,606 participants from 36 countries, including 329 in Canada. Participants should contact their study site for guidance on medication and should not stop treatment until they have seen their physician, Health Canada said.

Online:

Novartis, www.novartis.com/

Just Posted

Alberta oil curtailment rules extended to late 2020 as pipeline delays persist

CALGARY — A program that allows the Alberta government to impose production… Continue reading

Alberta city votes to keep money flowing to supervised drug consumption site

LETHBRIDGE — City council in Lethbridge has voted down a motion that… Continue reading

‘We’re going to act:’ Military investigating reservist for hate group link

Military probe reservist for hate group link WINNIPEG — The commander of… Continue reading

Military hopes for post-Norman stability as new army commander installed

OTTAWA — Cannons boomed on Parliament Hill Tuesday as the military installed… Continue reading

Trudeau says falling news revenues and tech giants will be discussed at G7 summit

Prime Minister Justin Trudeau says the issue of declining news revenues amid… Continue reading

Your community calendar

Thursday The Red Deer and District Garden Club hosts its annual Flower… Continue reading

Alberta oil curtailment rules extended to late 2020 as pipeline delays persist

CALGARY — A program that allows the Alberta government to impose production… Continue reading

Alberta city votes to keep money flowing to supervised drug consumption site

LETHBRIDGE — City council in Lethbridge has voted down a motion that… Continue reading

‘We’re going to act:’ Military investigating reservist for hate group link

Military probe reservist for hate group link WINNIPEG — The commander of… Continue reading

Military hopes for post-Norman stability as new army commander installed

OTTAWA — Cannons boomed on Parliament Hill Tuesday as the military installed… Continue reading

Trudeau says falling news revenues and tech giants will be discussed at G7 summit

Prime Minister Justin Trudeau says the issue of declining news revenues amid… Continue reading

Former child refugee from Somalia facing unfair deportation: advocates

HALIFAX — Refugee advocates have launched a last-minute appeal for an Edmonton… Continue reading

Leaders, moderators confirmed for 2019 English, French debates

OTTAWA — Five party leaders have confirmed they will participate in two… Continue reading

Most Read